|
PAST LETTERS FROM THE PRESIDENT |
![]() |
|
Differences
In The Reactive Hyperaemia Response Of Bone In Able Bodied And Spinal
Injured Persons Using Near Infrared Spectroscopy
|
|
|
R.S.Khakha, Z.Bloomer, D.Bain, G.Nicholson. A.Gall, M. Ferguson-Pell Aspire Centre for Disability Sciences, Institute of Orthopaedics & Musculoskeletal Sciences, Royal National Orthopaedic Hospital, University College London, UK Introduction: Studies have shown Near Infrared Spectroscopy (NIRS) as being an effective tool in measuring oxygenation non-invasively in tissues. More recently it has been used in clinical settings to assess circulatory and metabolic abnormalities, however, clinical studies in bone are lacking. Subjects: Ten able-bodied (AB) (5 men and 5 women; age, 23-40 years) and ten spinal cord injured (SCI) (complete cord transection above T10, 5 men and 5 women; age 19-38) participants, matched by age, gender, skin pigmentation. Materials and Methods: A spectrometer measured between 498-1000nm, at 0.2Hz , using glass optodes (2mm diameter). 5 minutes of resting readings, followed by 3 minutes of below knee arterial occlusion and then 6 minutes post-occlusion. The second study, started with 5 minutes of resting readings, vibration loading for 3 minutes at 30 Hz with acceleration of 3g and 6 minutes post-vibration. Results: NIRS shows changes in blood parameters during the hyperaemic response (avg. 97% increase in Hb from baseline, p<0.0001). AB have significantly quicker (p=0.01) capacity for HB to return to baseline. There was a significant difference (p=0.001) in the time to peak for Hb following arterial occlusion in the SCI group, 16.6 seconds (sd 4.3), and 10.1 seconds (sd 1.7) in the able bodied. Conclusion: Our findings suggest that there is a reduction in the bone’s ability to restore oxygenated blood in SCI participants compared to the AB participants. Future studies looking at changes in bone following a range of vibration amplitudes and frequencies in the SCI group should be considered using NIRS in order to optimise potential clinical benefits. |